{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:22:10Z","timestamp":1790036530576,"version":"4.0.1"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold><jats:italic>Ginkgo biloba<\/jats:italic> L. leaf extract (GBLE) has been reported to be effective for alleviating cognitive and memory impairment in Alzheimer\u2019s disease (AD). Nevertheless, the potential mechanism remains unclear. Herein, this study aimed to explore the neuroprotective effects of GBLE on AD and elaborate the underlying therapeutic mechanism.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Donepezil, the most widely prescribed drug for AD, was used as a positive control. An integrated metabolomics and lipidomics approach was adopted to characterize plasma metabolic phenotype of APP\/PS1 double transgenic mice and describe the metabolomic and lipidomic fingerprint changes after GBLE intervention. The Morris water maze test and immunohistochemistry were applied to evaluate the efficacy of GBLE.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> As a result, administration of GBLE significantly improved the cognitive function and alleviated amyloid beta (A\u03b2) deposition in APP\/PS1 mice, showing similar effects to donepezil. Significant alterations were observed in metabolic signatures of APP\/PS1 mice compared with wild type (WT) mice by metabolomic analysis. A total of 60 markedly altered differential metabolites were identified, including 28 lipid and lipid-like molecules, 13 organic acids and derivatives, 11 organic nitrogen compounds, and 8 other compounds, indicative of significant changes in lipid metabolism of AD. Further lipidomic profiling showed that the differential expressed lipid metabolites between APP\/PS1 and WT mice mainly consisted of phosphatidylcholines, lysophosphatidylcholines, triglycerides, and ceramides. Taking together all the data, the plasma metabolic signature of APP\/PS1 mice was primarily characterized by disrupted sphingolipid metabolism, glycerophospholipid metabolism, glycerolipid metabolism, and amino acid metabolism. Most of the disordered metabolites were ameliorated after GBLE treatment, 19 metabolites and 24 lipids of which were significantly reversely regulated (adjusted-<jats:italic>p<\/jats:italic>&amp;lt;0.05), which were considered as potential therapeutic targets of GBLE on AD. The response of APP\/PS1 mice to GBLE was similar to that of donepezil, which significantly reversed the levels of 23 disturbed metabolites and 30 lipids.<\/jats:p><jats:p><jats:bold>Discussion:<\/jats:bold> Our data suggested that lipid metabolism was dramatically perturbed in the plasma of APP\/PS1 mice, and GBLE might exert its neuroprotective effects by restoring lipid metabolic balance. This work provided a basis for better understanding the potential pathogenesis of AD and shed new light on the therapeutic mechanism of GBLE in the treatment of AD.<\/jats:p>","DOI":"10.3389\/fphar.2022.1076960","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T05:31:23Z","timestamp":1671600683000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Comprehensive metabolomics and lipidomics profiling uncovering neuroprotective effects of Ginkgo biloba L. leaf extract on Alzheimer\u2019s disease"],"prefix":"10.3389","volume":"13","author":[{"given":"Li-Wei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He-Ying","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan-Mei","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo-Lun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Quan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Hua","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/ca.980080612","article-title":"An English translation of Alzheimer's 1907 paper, \"Uber eine eigenartige Erkankung der Hirnrinde","volume":"8","author":"Alzheimer","year":"1995","journal-title":"Clin. Anat."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.3390\/ijms20092313","article-title":"Natural compounds for Alzheimer's disease therapy: A systematic review of preclinical and clinical studies","volume":"20","author":"Andrade","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e24777","DOI":"10.1371\/journal.pone.0024777","article-title":"Elevated stearoyl-CoA desaturase in brains of patients with Alzheimer's disease","volume":"6","author":"Astarita","year":"2011","journal-title":"PLoS One"},{"key":"B4","doi-asserted-by":"publisher","first-page":"8208","DOI":"10.1074\/jbc.RA118.001986","article-title":"Extracellular \u03b1-synuclein drives sphingosine 1-phosphate receptor subtype 1 out of lipid rafts, leading to impaired inhibitory G-protein signaling","volume":"293","author":"Badawy","year":"2018","journal-title":"J. Biol. Chem."},{"key":"B56","doi-asserted-by":"publisher","first-page":"12472","DOI":"10.3390\/ijms232012472","article-title":"Quantitative NMR-based lipoprotein analysis identifies elevated HDL-4 and triglycerides in the serum of Alzheimer\u2019s disease patients","volume":"23","author":"Berezhnoy","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"13188","DOI":"10.3390\/ijms222413188","article-title":"Serum metabolomic and lipidomic profiling reveals novel biomarkers of efficacy for Benfotiamine in Alzheimer's disease","volume":"22","author":"Bhawal","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.3390\/molecules25245789","article-title":"Comprehensive review on Alzheimer\u2019s disease: Causes and treatment","volume":"25","author":"Breijyeh","year":"2020","journal-title":"Molecules"},{"key":"B7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1146\/annurev-biochem-060713-035324","article-title":"Lipidomics: Analysis of the lipid composition of cells and subcellular organelles by electrospray ionization mass spectrometry","volume":"83","author":"Br\u00fcgger","year":"2014","journal-title":"Annu. Rev. Biochem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"113646","DOI":"10.1016\/j.jep.2020.113646","article-title":"Untargeted metabolomics and lipidomics uncovering the cardioprotective effects of Huanglian Jiedu Decoction on pathological cardiac hypertrophy and remodeling","volume":"270","author":"Chen","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jchromb.2016.02.007","article-title":"Metabolomics approach to explore the effects of Kai-Xin-San on Alzheimer's disease using UPLC\/ESI-Q-TOF mass spectrometry","author":"Chu","year":"2016","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1126\/science.7770779","article-title":"Chemical characterization of a family of brain lipids that induce sleep","volume":"268","author":"Cravatt","year":"1995","journal-title":"Science"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1073\/pnas.0305799101","article-title":"Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease","volume":"101","author":"Cutler","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"904857","DOI":"10.3389\/fphar.2022.904857","article-title":"Comparative metabolomics analysis reveals key metabolic mechanisms and protein biomarkers in Alzheimer's disease","volume":"13","author":"Dai","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1194\/jlr.E400004-JLR200","article-title":"A comprehensive classification system for lipids","volume":"46","author":"Fahy","year":"2005","journal-title":"J. Lipid Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.plipres.2011.06.001","article-title":"Glycerophospholipids and glycerophospholipid-derived lipid mediators: A complex meshwork in Alzheimer's disease pathology","volume":"50","author":"Frisardi","year":"2011","journal-title":"Prog. Lipid Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S1474-4422(18)30403-4","article-title":"Global, regional, and national burden of Alzheimer's disease and other dementias, 1990\u20132016: A systematic analysis for the global burden of disease study 2016","volume":"18","year":"2019","journal-title":"Lancet Neurol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jprot.2014.01.014","article-title":"Combination of metabolomic and phospholipid-profiling approaches for the study of Alzheimer's disease","volume":"104","author":"Gonz\u00e1lez-Dom\u00ednguez","year":"","journal-title":"J. Proteomics"},{"key":"B17","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jpba.2014.05.023","article-title":"Metabolomic study of lipids in serum for biomarker discovery in Alzheimer's disease using direct infusion mass spectrometry","volume":"98","author":"Gonz\u00e1lez-Dom\u00ednguez","year":"","journal-title":"J. Pharm. Biomed. Anal."},{"key":"B18","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3390\/biomedicines9030298","article-title":"Mechanistic insights into Alzheimer's disease unveiled through the investigation of disturbances in central metabolites and metabolic pathways","volume":"9","author":"Gonz\u00e1lez-Dom\u00ednguez","year":"2021","journal-title":"Biomedicines"},{"key":"B19","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3390\/metabo8030052","article-title":"High-throughput direct mass spectrometry-based metabolomics to characterize metabolite fingerprints associated with Alzheimer's disease pathogenesis","volume":"8","author":"Gonz\u00e1lez-Dom\u00ednguez","year":"2018","journal-title":"Metabolites"},{"key":"B20","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/nrendo.2016.98","article-title":"Lipidomics for studying metabolism","volume":"12","author":"Han","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"9291","DOI":"10.1038\/s41598-018-27031-x","article-title":"Comparative evaluation of MS-based metabolomics software and its application to preclinical Alzheimer's disease","volume":"8","author":"Hao","year":"2018","journal-title":"Sci. Rep."},{"key":"B22","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.neurobiolaging.2008.05.010","article-title":"Deregulation of sphingolipid metabolism in Alzheimer's disease","volume":"31","author":"He","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"B23","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1002\/ijc.31925","article-title":"Serum-plasma matched metabolomics for comprehensive characterization of benign thyroid nodule and papillary thyroid carcinoma","volume":"144","author":"Huang","year":"2019","journal-title":"Int. J. Cancer"},{"key":"B24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.neurobiolaging.2019.10.014","article-title":"Brain and blood metabolome for Alzheimer\u2019s dementia: Findings from a targeted metabolomics analysis","volume":"86","author":"Huo","year":"2020","journal-title":"Neurobiol. Aging"},{"key":"B25","doi-asserted-by":"publisher","first-page":"5698","DOI":"10.1038\/s41467-020-19473-7","article-title":"Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer's disease","volume":"11","author":"Huynh","year":"2020","journal-title":"Nat. Commun."},{"key":"B26","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3233\/JAD-2011-101608","article-title":"Disturbed choline plasmalogen and phospholipid fatty acid concentrations in Alzheimer's disease prefrontal cortex","volume":"24","author":"Igarashi","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.plipres.2009.08.004","article-title":"Acylcarnitines: Role in brain","volume":"49","author":"Jones","year":"2010","journal-title":"Prog. Lipid Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s11064-007-9297-x","article-title":"Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer's disease: A shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer's disease?","volume":"32","author":"Katsel","year":"2007","journal-title":"Neurochem. Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.jalz.2019.03.004","article-title":"Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort","volume":"15","author":"Kim","year":"2019","journal-title":"Alzheimers Dement."},{"key":"B30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B31","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.neulet.2012.04.019","article-title":"Elevated cerebrospinal fluid sphingomyelin levels in prodromal Alzheimer's disease","volume":"516","author":"Kosicek","year":"2012","journal-title":"Neurosci. Lett."},{"key":"B32","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.biopha.2018.04.125","article-title":"Investigation of Ginkgo biloba extract (EGb 761) promotes neurovascular restoration and axonal remodeling after embolic stroke in rat using magnetic resonance imaging and histopathological analysis","volume":"103","author":"Li","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"B33","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3389\/fphar.2020.00502","article-title":"Metabolomic insights into the synergistic effect of biapenem in combination with Xuebijing injection against sepsis","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1194\/jlr.D700041-JLR200","article-title":"Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics","volume":"49","author":"Matyash","year":"2008","journal-title":"J. Lipid Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.3390\/ijms20153810","article-title":"Lipid and lipid raft alteration in aging and neurodegenerative diseases: A window for the development of new biomarkers","volume":"20","author":"Mesa-Herrera","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"775034","DOI":"10.3389\/fphar.2021.775034","article-title":"The use of Ginkgo biloba L. as a neuroprotective agent in the Alzheimer's disease","volume":"12","author":"Nowak","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"5030","DOI":"10.3390\/jcm11175030","article-title":"Plasma lipidomics approach in early and specific Alzheimer\u2019s disease diagnosis","volume":"11","author":"Pe\u00f1a-Bautista","year":"2022","journal-title":"J. Clin. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s11011-021-00673-z","article-title":"Metabolic disorder in Alzheimer's disease","volume":"36","author":"Poddar","year":"2021","journal-title":"Metab. Brain Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"178910","DOI":"10.1155\/2013\/178910","article-title":"Sphingolipid metabolic pathway: An overview of major roles played in human diseases","volume":"2013","author":"Pralhada Rao","year":"2013","journal-title":"J. Lipids"},{"key":"B39","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2174\/157015909789152119","article-title":"The role of adenosine in Alzheimer's disease","volume":"7","author":"Rahman","year":"2009","journal-title":"Curr. Neuropharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"603052","DOI":"10.4061\/2011\/603052","article-title":"Lipid rafts: Linking Alzheimer's amyloid-\u03b2 production, aggregation, and toxicity at neuronal membranes","volume":"2011","author":"Rushworth","year":"2010","journal-title":"Int. J. Alzheimers Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1017\/S1041610217001892","article-title":"Treatment effects of ginkgo biloba extract EGb 761\u00ae on the spectrum of behavioral and psychological symptoms of dementia: meta-analysis of randomized controlled trials","volume":"30","author":"Savaskan","year":"2018","journal-title":"Int. Psychogeriatr."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer\u2019s disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"B43","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/2047-9158-2-6","article-title":"Traditional Chinese medicine: A promising candidate for the treatment of Alzheimer\u2019s disease","volume":"2","author":"Sun","year":"2013","journal-title":"Transl. Neurodegener."},{"key":"B44","doi-asserted-by":"publisher","first-page":"101595","DOI":"10.1016\/j.arr.2022.101595","article-title":"Anthocyanin as a therapeutic in Alzheimer's disease: A systematic review of preclinical evidences","volume":"76","author":"Suresh","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"B45","doi-asserted-by":"publisher","first-page":"8288818","DOI":"10.1155\/2022\/8288818","article-title":"Ginkgo biloba: A treasure of functional phytochemicals with multimedicinal applications","volume":"2022","author":"Tabassum","year":"2022","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"6850","DOI":"10.1523\/JNEUROSCI.6467-10.2011","article-title":"BACE1 activity is modulated by cell-associated sphingosine-1-phosphate","volume":"31","author":"Takasugi","year":"2011","journal-title":"J. Neurosci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.jalz.2017.01.020","article-title":"Metabolic network failures in Alzheimer's disease: A biochemical road map","volume":"13","author":"Toledo","year":"2017","journal-title":"Alzheimers Dement."},{"key":"B48","doi-asserted-by":"publisher","first-page":"541","DOI":"10.4155\/bio.13.346","article-title":"Lipidomics of Alzheimer's disease","volume":"6","author":"Touboul","year":"2014","journal-title":"Bioanalysis"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e1002482","DOI":"10.1371\/journal.pmed.1002482","article-title":"Brain and blood metabolite signatures of pathology and progression in alzheimer disease: A targeted metabolomics study","volume":"15","author":"Varma","year":"2018","journal-title":"PLoS Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"700587","DOI":"10.3389\/fphar.2021.700587","article-title":"Biomarkers for the clinical diagnosis of Alzheimer's disease: Metabolomics analysis of brain tissue and blood","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.phymed.2016.03.005","article-title":"Targeted metabolomic profiling of cardioprotective effect of Ginkgo biloba L. extract on myocardial ischemia in rats","volume":"23","author":"Wang","year":"2016","journal-title":"Phytomedicine"},{"key":"B52","doi-asserted-by":"publisher","first-page":"719159","DOI":"10.3389\/fneur.2021.719159","article-title":"Alterations in glycerolipid and fatty acid metabolic pathways in Alzheimer's disease identified by urinary metabolic profiling: A pilot study","volume":"12","author":"Watanabe","year":"2021","journal-title":"Front. Neurol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.neurobiolaging.2013.08.001","article-title":"Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease","volume":"35","author":"Whiley","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"B54","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.jalz.2017.01.008","article-title":"Dysregulation of lipids in Alzheimer\u2019s disease and their role as potential biomarkers","volume":"13","author":"Wong","year":"2017","journal-title":"Alzheimers Demen"},{"key":"B55","doi-asserted-by":"publisher","first-page":"S177","DOI":"10.37765\/ajmc.2020.88482","article-title":"Economic burden of Alzheimer disease and managed care considerations","volume":"26","author":"Wong","year":"2020","journal-title":"Am. J. Manag. Care"},{"key":"B57","doi-asserted-by":"publisher","first-page":"5243453","DOI":"10.1155\/2020\/5243453","article-title":"Integrated metabolomic and lipidomic analysis reveals the neuroprotective mechanisms of Bushen Tiansui formula in an A\u03b21-42-induced rat model of Alzheimer's Disease","volume":"2020","author":"Yi","year":"2020","journal-title":"Oxid. Med. Cell Longev."},{"key":"B59","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jpha.2020.06.002","article-title":"Neuroprotective effects of Ginkgo biloba dropping pills in Parkinson's disease","volume":"11","author":"Yu","year":"2021","journal-title":"J. Pharm. Anal."},{"key":"B60","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.neuropharm.2015.05.007","article-title":"Neuronal histamine and cognitive symptoms in Alzheimer's disease","volume":"106","author":"Zlomuzica","year":"2016","journal-title":"Neuropharmacology"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1076960\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T05:31:26Z","timestamp":1671600686000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1076960\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,21]]},"references-count":60,"alternative-id":["10.3389\/fphar.2022.1076960"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.1076960","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,21]]},"article-number":"1076960"}}